Insider Transactions in Q2 2022 at Mirum Pharmaceuticals, Inc. (MIRM)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 06
2022
|
James E Flynn > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
38,478
-0.39%
|
$923,472
$24.95 P/Share
|
|
May 10
2022
|
Ian Clements Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,125
+3.65%
|
$14,625
$13.57 P/Share
|
|
May 10
2022
|
Christopher Peetz CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
1,500
+2.11%
|
$19,500
$13.57 P/Share
|
|
May 10
2022
|
Pamela Vig CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
807
+3.66%
|
$10,491
$13.57 P/Share
|
|
May 10
2022
|
Lara Longpre CHIEF DEVELOPMENT OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
1,454
+1.49%
|
$18,902
$13.57 P/Share
|
|
May 10
2022
|
Peter Radovich PRESIDENT AND COO |
BUY
Grant, award, or other acquisition
|
Direct |
1,169
+4.76%
|
$15,197
$13.57 P/Share
|